Commitments and Contingencies - Contingent Consideration and Employee Retention Bonus (Details) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Feb. 25, 2019 |
|
| Commitments And Contingencies | |||
| Contingent consideration under RPAs and CPPAs | $ 75,000 | $ 8,075,000 | |
| Aronora, Kuros, Affitech, ObsEva, and Merck KGaA | Royalty milestones, sales milestones, non-sales milestones, and royalties | |||
| Commitments And Contingencies | |||
| Contingent consideration under RPAs and CPPAs | 0 | ||
| Royalty Purchase Agreement | Bioasis | |||
| Commitments And Contingencies | |||
| Contingent consideration under RPAs and CPPAs | 100,000 | $ 100,000 | |
| Changes in estimated fair value of contingent consideration | $ 0 |
| X | ||||||||||
- Definition Changes in estimated fair value of contingent consideration. No definition available.
|
| X | ||||||||||
- Definition Commitments and contingencies. No definition available.
|
| X | ||||||||||
- Definition Liability recorded for contingent consideration under purchase agreements. May include royalty purchase agreements and commercial payment purchase agreements. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|